Senior Director, New Ventures
Johnson & Johnson Innovation, New Ventures Lead, California
Tatyana focuses on sourcing, catalyzing and investing in external innovation opportunities across all healthcare sectors that are of strategic interest to Johnson & Johnson. At J&J Innovation, our vision is to positively impact human health through external innovation. We do this by helping entrepreneurs realize their dreams of creating healthcare solutions that improve peoples’ lives around the world. We work side-by-side with innovators throughout their journey, providing a robust exchange of ideas and resources to support their success.
Tatyana brings nearly two decades of diverse experience spanning all healthcare sectors and a track record of success as a venture capital investor, business development professional, entrepreneur, and investment research analyst. Previously, she founded and ran an investment advisory company, FireRock Advisors, to source and evaluate investments in healthcare innovation for private equity, venture capital and family office clients. As an entrepreneur, Tatyana founded and became CEO of a consumer healthcare company, Slim & Sage, featured on Good Morning America, in The New York Times, and Marie Claire. Previously, she was a Principal at Technology Partners, where she helped source or fund consumer health, medical device, and biopharma venture investments that subsequently created realized shareholder value of over $2B. Earlier, Tatyana held strategy and business development positions at Johnson & Johnson and at Pfizer. Tatyana began her career as a financial analyst for Salomon Smith Barney and as a medical devices investment research associate at JP Morgan H&Q. Tatyana earned a B.S. with honors from Carnegie Mellon University, and an MBA from the Harvard Business School.